Skip to main content

Table 3 Summary of HCMV-tetramer in HLA-A2 young children

From: Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses

Age(yr.) (n = 179)

< 1 (n = 60)

1 (n = 45)

2 (n = 30)

3 (n = 27)

4 (n = 17)

Number of tet(+)

14(23%)

17(38%)

9(30%)

11(41%)

4(24%)

CD8

18.1 ± 5.1

16.7 ± 4.1

22.5 ± 3.5

19.7 ± 4.4

20.1 ± 5.1

Tet(%)

0.20 ± 0.20

0.25 ± 0.32

0.17 ± 0.19

0.15 ± 0.14

0.08 ± 0.05

Tet/CD8(%)

1.16 ± 1.13

1.48 ± 1.78*

0.73 ± 0.77*

0.75 ± 0.65*

0.28 ± 0.26*

  1. HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.05%
  2. *: P values < 0.05
Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us